SEC Form 4 · accession 0001237899-18-000011
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph L Goldstein
Director
Period of report
Feb 9, 2018
Accepted (ET)
Feb 13, 2018 · 4:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 9, 2018 | S | 1,000 | $325.60 | D | 12,000 | D |
Table II — derivative securities
No Table II lines on this filing.